To prove whether GASP1 regulates IGF1R stability, we treated breast cancer cells with protein synthesis inhibitor CHX and then performed western blot analysis to evaluate the protein expression of IGF1R upon GASP1 knockout or overexpression. Here, IGF1R is linked to breast carcinoma.